➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Moodys
Mallinckrodt
Johnson and Johnson
Dow

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANDROGEL

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Androgel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00112151 TEAM: Testosterone Supplementation and Exercise in Elderly Men Completed National Institute on Aging (NIA) Phase 2 2005-01-01 The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00112151 TEAM: Testosterone Supplementation and Exercise in Elderly Men Completed University of Colorado, Denver Phase 2 2005-01-01 The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00114114 Dose-Response of Gonadal Steroids and Bone Turnover in Men Recruiting AbbVie N/A 2004-09-01 The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Androgel

Condition Name

Condition Name for Androgel
Intervention Trials
Hypogonadism 10
Secondary Hypogonadism 4
Healthy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Androgel
Intervention Trials
Hypogonadism 20
Diabetes Mellitus 4
Prostatic Neoplasms 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Androgel

Trials by Country

Trials by Country for Androgel
Location Trials
United States 127
Canada 7
Netherlands 2
Germany 2
France 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Androgel
Location Trials
New York 12
Texas 11
California 9
Washington 8
Florida 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Androgel

Clinical Trial Phase

Clinical Trial Phase for Androgel
Clinical Trial Phase Trials
Phase 4 9
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Androgel
Clinical Trial Phase Trials
Completed 22
Not yet recruiting 9
Withdrawn 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Androgel

Sponsor Name

Sponsor Name for Androgel
Sponsor Trials
Solvay Pharmaceuticals 9
Repros Therapeutics Inc. 4
University of Washington 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Androgel
Sponsor Trials
Other 31
Industry 26
NIH 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Colorcon
Harvard Business School
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.